Regarding SETD2, we also identified two somatic mutations in two distinct ccRCC cases consisting of a missense mutation (p.W1562C) and a stop-gain mutation (p.S512X). The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.